Zanger UM, Raimundo S, Eichelbaum M

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.

Naunyn Schmiedebergs Arch Pharmacol 369:23-37 (2004)
DOI:10.1007/s00210-003-0832-2

Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.

Clin Pharmacol Ther 98:127-34 (2015)
DOI:10.1002/cpt.147

Zhou SF

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Clin Pharmacokinet 48:689-723 (2009)
DOI:10.2165/11318030-000000000-00000

Gardiner SJ, Begg EJ

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice.

Pharmacol Rev 58:521-90 (2006)
DOI:10.1124/pr.58.3.6